Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY | MicrobiomeTrials← Back to trialsNCT05485831
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
RecruitingOBSERVATIONAL
Trial Details
Start: 2025-02-24Est. Completion: 2027-02
Enrollment target: 111 participants Locations- Policlinico Sant'Orsola di Bologna, Bologna, Italy
- NPI AOU Mater Domini Università Magna Graecia, Catanzaro, Italy
- Università degli studi "G. D'annunzio" Chieti, Chieti, Italy
- Azienda Ospedaliera Universitaria Meyer Neurologia Pediatrica, Florence, Italy
- Istituto Gaslini Neurologia Pediatrica e Malattie Muscolari, Genova, Italy
- AOU Gaetano Martino, Messina, Italy
- Centro Regionale Epilessia - ASST Santi Paolo e Carlo, Milan, Italy
- ASST Grande Ospedale metropolitano Niguarda, Milan, Italy
- Azienda Ospedaliera Universitaria Federico II, Naples, Italy
- AOU Maggiore della Carità di Novara, Novara, Italy
- AOU di Padova, Padova, Italy
- Policlinico Tor Vergata, Roma, Italy
- IRCCS Ospedale Pediatrico Bambin Gesù, Roma, Italy
- Fondazione Policlinico Universitario Agostino Gemelli - IRCCS-NPI, Roma, Italy
- Azienda Ospedaliero Universitaria Sant'Andrea, Roma, Italy
- Ospedale Casa del sollievo e della sofferenza, San Giovanni Rotondo, Italy
- AOU Città della Salute PO Molinette, Torino, Italy
Other microbiome trials you might be interested in
Dravet Syndrome (DS)Lennox Gastaut Syndrome (LGS)
The main aim of the study is to learn if soticlestat, when given as an add-on therapy, reduces the number of seizures in…
Phoenix, United StatesCompleted Sep 24, 2025
Focal Seizures
Cannabidiol oral solution (CBD-OS) is approved in the US for the treatment of seizures associated with Lennox-Gastaut sy…
Phoenix, United StatesEst. completion Nov 29, 2027
Azienda Ospedaliero Universitaria delle Marche, Torrette, Italy